2012 BIO India Keynote Speaker
 |
Alan F. Eisenberg Alan F. Eisenberg serves as Executive Vice President for Emerging Companies & Business Development at the Biotechnology Industry Organization (BIO). In this role, Eisenberg manages and directs BIO’s services and advocacy efforts for BIO's 650+ emerging companies, which comprise approximately 90% of BIO's membership. This includes tax, capital formation, financial services, and selected health policy development and advocacy, BIO's global portfolio of investor and partnering events, industry research and analysis, and BIO's affinity purchasing program enrolling over 2,000 companies. Previously at BIO, Eisenberg served in other senior leadership roles, including responsibilities for BIO’s communications function, as well as state government relations, Board operations, and BIO’s political action committee. From 2001 through 2004, Eisenberg served as Health and Economics Policy Adviser to BIO CEO Jim Greenwood during his tenure in Congress. In this role, Eisenberg was extensively involved in the enactment of several public laws including the Medical Device User Fee and Modernization Act (P.L. 107-250), the Best Pharmaceuticals for Children Act (P.L. 107-109), as well as key provisions of the Medicare Modernization Act (P.L.108-173). Prior to that, Eisenberg briefly served on the staff of the Senate Health, Education, Labor and Pensions Public Health Subcommittee as Health Policy Adviser and also was a legislative assistant for Congressman John Shadegg (R-AZ). Before coming to Washington, Eisenberg spent four years with Ford Motor Company in Dearborn, MI, as a research economist and finance manager in manufacturing. As an economist, Eisenberg was responsible for conducting and overseeing the development of analyses relating to a variety of energy, regulatory and tax matters. Eisenberg holds a Master in Public Policy degree from Harvard University (Kennedy School of Government), a Master of Science in Finance degree from George Washington University, and a Bachelor of Science degree from Union College. |
 |
P.M. Murali, PhD Dr. P.M. Murali is currently Managing Director of the Swiss International Drug Discovery Company Evolva Biotech and also the President and CEO of Evolva Inc, USA. He established Evolva Biotech as India's unique public private partnership in Hyderabad, India before it moved to Chennai. Dr. Murali has a PhD in Microbiology from Madurai Kamaraj University and a D.Sc. with over 20 years of experience in Pharmaceutical/FMCG R&D. He was the Founder and Director of the Dalmia Centre for Research and Development for 16 years and prior to this he has worked as an Indo-US Researcher at the Battelle-Kettering Research Centre, Ohio. He serves as the Chairman of the Biotech panel for Tamil Nadu with the Confederation of Indian Industries Tamil Nadu and also as the President of Association of Biotech Led Enterprises (ABLE) the only Industry body for Biotechnology in India. Dr. Murali guides students for their PhD at the Bharathiar University and is an Adjunct Professor of the Deakin University in Australia. |
 |
Kiran Mazumdar-Shaw
A successful technocrat of global standing, Ms. Shaw Dr. Kiran Mazumdar-Shaw founded Biocon Ltd. in 1978 and has been its Chairman and Managing Director since April 1, 2005. She is a first generation entrepreneur with more than 30 years' experience in the field of biotechnology and industrial enzymes. Dr. Shaw heads several biotechnology task forces including the Karnataka Vision Group on Biotechnology, an initiative by the Government of Karnataka and the National Taskforce on Biotechnology for the Confederation of Indian Industry (CII). Dr. Shaw is the recipient of several awards, the most noteworthy being the 'Padmashri' Award (one of the highest civilian awards in India) in 1989 conferred by the President of India and also awarded the Padmabhushan, one of India's highest civilian awards for her pioneering efforts in Biotechnology, 2005 and the Ernst & Young Entrepreneur of the Year Award in 2002 for the Healthcare & Life Sciences category and more recently in 2003 the BioSpectrum Person of the Year Award. Dr. Shaw graduated in BSc (Zoology Hons.) from Bangalore University in 1973; she completed her post-graduate degree in malting and brewing from Ballarat College, Melbourne University in 1975. She has also been awarded honorary doctorates from the University of Abertay, Dundee, UK (2007), the University of Glasgow, UK (2008) and Heriot-Watt University, Edinburgh, UK (2008). |
 |
Sam Pitroda
Sam Pitroda is an internationally respected development thinker, policy maker, telecom inventor and entrepreneur who has spent over four decades in Information and Communications Technology and related human and national Credited with having laid the foundation of India's technology and telecommunications revolution in the 1980s, Mr. Pitroda has been a leading campaigner to help bridge the global digital divide. During his tenure as Adviser to Prime Minister Rajiv Gandhi in the 1980s, Mr. Pitroda headed six technology missions related to telecommunications, water, literacy, immunization, dairy and oil seeds. He was also the founder and first chairman of India's Telecom Commission. In these roles, he helped revolutionise India’s development policies and philosophies with a focus on access to technology as the key to social change.
Mr. Pitroda was Chairman of India's National Knowledge Commission (2005–2009), an advisory body to the Prime Minister of India, set up to provide a blueprint for reform
He is currently Adviser to the Prime Minister of India on Public Information Infrastructure and Innovations and has undertaken the ambitious task of providing a plan for creating digital infrastructure in the country for enhancing governance and improving delivery of public services. He is also the Chairman of the National Innovation Council (NInC) which is working on several initiatives to boost innovation performance in the country. Mr. Pitroda also chaired the Expert Group for He holds close to 100 worldwide patents and has published and lectured widely in the US, Europe, Latin America and Asia. |
 |
H. Thomas Watkins H. Thomas Watkins joined HGS as Chief Executive Officer and a Director in December 2004, and was also named President in December 2005. Mr. Watkins came to HGS with nearly twenty years of experience at Abbott Laboratories and its affiliates in the U.S. and Asia. Mr. Watkins began his career in 1974 with Arthur Andersen & Co., and was a management consultant with McKinsey and Company, Inc., from 1979 to 1985. He holds a bachelor’s degree from the College of William and Mary, and a master’s degree in business administration from the University of Chicago Graduate School of Business. Mr. Watkins is Chair of the Board of Directors of the Biotechnology Industry Organization (BIO) and Chair of the Life Sciences Advisory Board of the State of Maryland. He is a member of the Boards of Directors of Vanda Pharmaceuticals, Inc., the U.S. Chamber of Commerce, and the National Symphony Orchestra. He is also Chair of The College of William and Mary Foundation Board of Trustees and a member of the Board of Trustees of The Mason School of Business of The College of William and Mary. |
Local Co-Host
Double Helix Sponsors
Conference Sponsors
Media Partners
